Nonetheless, in a national survey of the Portuguese population, 13.8% of the participants reported having been screened only through DRE, 12.2% only through PSA testing, and 18.2% with both tests, indicating that these PCa screening methods are similarly used [82]. The gene discussed is KLK3; the disease is posterior cortical atrophy.